Gyre Therapeutics, Inc. GYRE Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Gyre Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s quick ratio?
- Gyre Therapeutics, Inc. (GYRE) reported quick ratio of 4.1× in Q1 2026.
- How has Gyre Therapeutics, Inc.'s quick ratio changed year-over-year?
- Gyre Therapeutics, Inc.'s quick ratio increased by 27.4% year-over-year, from 3.2× to 4.1×.
- What is the long-term trend for Gyre Therapeutics, Inc.'s quick ratio?
- Over 5 years (2020 to 2025), Gyre Therapeutics, Inc.'s quick ratio has grown at a 0.0% compound annual growth rate (CAGR), from 5× to 5×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.